ICBCCS S&P China 500 Review: Investing Guide & Fees

I have a confession: I almost bought the ICBCCS S&P China 500 without reading the fee schedule. That would have been a mistake. After two years of holding this fund, I’ve learned more about how it actually works than the product brochure will ever tell you. Let me break it down clearly, with the good, the bad, and the stuff your financial advisor probably forgot to mention.

What Is the ICBCCS S&P China 500?

The ICBCCS S&P China 500 is a mutual fund offered by ICBC Credit Suisse Asset Management that tracks the S&P China 500 Index. This index is designed to measure the performance of 500 leading Chinese companies listed across A-shares (Shanghai and Shenzhen), H-shares (Hong Kong), and US-listed ADRs. So you’re getting broad China exposure — not just internet stocks or banks, but the whole economy.

What makes it different from MSCI China or the CSI 300? The S&P China 500 includes both A-shares and overseas-listed Chinese companies, giving you a more complete picture. For example, Alibaba and Tencent are included even though they aren’t listed in mainland China. That’s why I prefer this over a pure A-share index when I want the “real China” exposure.

One thing I didn’t realize at first: the fund uses a sampling strategy rather than buying all 500 stocks equally. That means it picks a representative basket to keep trading costs down. It’s cheaper but can cause slight tracking error. Not a huge deal, but you should know it before comparing performance to the index.

How to Buy ICBCCS S&P China 500

This fund is primarily targeted at mainland Chinese investors through ICBC Credit Suisse’s platform or major Chinese distributors like Alipay’s Ant Fortune or Tencent’s Licaitong. If you’re living in China, you can open an account with ICBC Credit Suisse and buy it directly. The minimum initial investment is typically around 100 RMB (roughly $14), which is nice for beginners.

But if you’re outside China, it’s harder. I’m based in Hong Kong, and my brokerage doesn’t list this fund. You might find it available on some cross-border platforms, but the trading fees and paperwork are painful. Instead, I suggest international investors consider a similar ETF like the iShares MSCI China ETF (MCHI) or the KraneShares CSI China Internet ETF (KWEB). They trade on US exchanges and give you comparable exposure.

Step-by-Step Purchase Process in China

• Step 1: Download the ICBC Credit Suisse app (or use a licensed distributor).
• Step 2: Verify your identity and link your bank account.
• Step 3: Search for “ICBCCS S&P China 500” in the fund catalogue.
• Step 4: Decide how much to invest — you can start small.
• Step 5: Review the fee disclosure and confirm the purchase.

Don’t skip step 5. I remember the first time I bought it, I was so excited that I nearly missed the “front-end sales fee” of 1.2% that gets deducted immediately. That’s a lot compared to US ETFs. If you hold for more than two years, the fee usually drops to zero, so treat this as a long-term hold.

Fees: The Real Cost of Owning This Fund

Let’s talk about money because this is where most investors get burned. The ICBCCS S&P China 500 has a management fee and a custody fee that together sum up to roughly 0.60% per year. That’s not outrageous, but it’s higher than many US index funds. Plus, there is a sales service fee depending on where you buy. I calculated that the total annual cost is closer to 0.85% if you include all expenses. Over ten years, that extra 0.25% can eat into your returns significantly.

Here’s a breakdown I made from the prospectus:

You might think the 0.60% expense ratio is similar to other China ETFs, but there’s also the front-end load. When I bought $1,000, I immediately lost $12 to the sales fee. That’s not a dealbreaker, but you should factor that into your expected return.

ICBCCS S&P China 500 vs. Other China Funds

I’ve compared this fund to the most common alternatives for China exposure. Here’s how it stacks up:

Notice that the ICBCCS fund’s main advantage is its broad coverage — it includes companies listed on three different markets. But for an investor outside China, MCHI gives you nearly the same thing with fewer headaches. I personally use MCHI in my US account and the ICBCCS fund in my RMB account.

Risks That Aren’t in the Brochure

Every fund prospectus lists “market risk” and “currency risk,” but there are a few risks specific to this fund that I rarely hear discussed.

Tracking Error from Sampling

Because the fund doesn’t replicate the index exactly, you’ll see small deviations. I noticed that in some months, the fund returns lagged the index by 0.3%. That’s significant if you’re a precision-obsessed investor. Always compare the fund’s actual NAV return to the index, not just the share price.

QDII Quota Restrictions

This fund is a QDII product, meaning it has a quota from the Chinese government for investing overseas. When the quota runs out, the fund may suspend purchases. That happened to me once — I tried to add more money and got an error message saying “subscription temporarily closed.” This liquidity risk into a market downturn is the last thing you want.

Currency Exposure

The fund invests in Hong Kong and US shares but reports in RMB. If the RMB strengthens, your returns get hammered even if the underlying stocks do well. For an investor holding RMB, that’s fine, but for foreigners, understand that this isn’t a pure “China equity” bet — it’s a China equity plus currency bet.

Who Should Actually Invest in This Fund?

In my mind, this fund is a great fit for:

• Chinese retail investors who want broad global China exposure without opening a securities account overseas.
• Long-term investors (5+ years) who can tolerate short-term tracking error and fee complexity.
• Investors who already have A-share exposure but want more Hong Kong/US-listed Chinese companies.

But I would steer away if you are:

• A short-term trader looking for liquidity (this fund can be delayed on redemptions).
• A non-resident looking for simple access — use MCHI instead.
• Someone who hates variable fees — read the fine print carefully.

My Experience with This Fund

I’ll tell you exactly what happened. I bought this fund after reading a research report that praised its broad index. I put in 20,000 RMB. Two months later, I noticed my account balance was lower than expected, even though the market had gone up. I dug into the fee schedule and discovered the 1.2% sales charge and a daily management fee. It took me an afternoon to compute the exact hit. That’s when I realized the importance of reading the prospectus.

Another surprise: quarterly dividends. The fund distributes dividends, but they’re tiny — my first dividend was 68.30 RMB on a 20,000 RMB investment, which is around 0.34% per quarter. Not bad if you reinvest, but not something you can live on.

I also made the mistake of trying to redeem quickly once when I needed cash for a down payment. The redemption request took 3 business days to process, plus transfer time. That’s slower than US ETFs. Lesson: keep your emergency fund elsewhere.

Despite these annoyances, I still hold the fund. The broad exposure helped me capture companies like CATL and BYD that are often missing in pure overseas-listed China funds. But I’ve also learned to check the tracking error monthly and set aside the cost in my mind.

FAQ: What Investors Ask Me